Haprolid and Derivatives Thereof as Inhibitors of HCV

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20140256618A1
SERIAL NO

13985897

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention describes new compounds (e.g. Haprolid) of formula (I) and their use as antiviral agents such as inhibitors of hepatitis C virus (HCV):

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
HELMHOLTZ-ZENTRUM FUER INFEKTIONSFORSCHUNG GMBHINHOFFENSTRASSE 7 BRAUNSCHWEIG D-38124

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Drobnik, Juliane Zurich, CH 2 0
Kunze, Brigitte Braunschweig, DE 9 18
Pietschmann, Thomas Hannover, DE 9 0
Steinmetz, Heinrich Hildesheim, DE 26 171

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation